Serial no.

Age

Sex

Clinical Response

% Reduction in Parasitaemia

Route of Administration I.M/P.O

Serum Lipid Profile Change

TG

T.Chol

HDL-C

LDL-C

VLDL-C

Abs Change (mmol/L)

% Change

Abs Change (mmol/L)

%

Change

Abs Change (mmol/L)

%

Change

Abs Change (mmol/L)

%

Change

Abs Change (mmol/L)

%

Change

1

39

F

2+

86%

IM

+0.1

8%

+0.3

9%

−0.1

11%

+1.8

95%

−0.1

17%

2

3

M

1+

50%

PO

+0.5

45%

+1.6

59%

0

0%

+1.4

93%

+0.2

40%

3

38

M

2+

60%

IM

+0.7

54%

−0

0%

−0.3

25%

0

0%

+0.3

50%

4

25

M

0

9%

IM

+0.3

30%

+0.2

4%

−0.5

38%

+0.6

19%

+0.1

20%

5

44

F

1+

58%

IM

−0.1

8%

+0.3

6%

−0.3

27%

+0.7

23%

−0.1

17%

6

3

M

1+

52%

PO

+0.3

23%

+0.1

3%

−0.3

30%

+0.3

17%

+0.1

17%

7

44

M

1+

60%

IM

+0.5

36%

+0.8

15%

0

0%

+0.5

14%

+0.3

50%

8

38

M

2+

82%

IM

+0.4

40%

−0.5

11%

+0.1

10%

−0.7

22%

+0.1

20%

9

14

F

1+

57%

PO

+0.1

9%

−0.6

16%

+0.1

14%

−0.7

28%

0

0%

10

22

F

2+

86%

IM

+0.5

28%

−0.9

15%

−0.2

14%

−0.9

24%

+0.2

25%

11

15

F

1+

50%

IM

−0.4

24%

−0.2

5%

+0.2

20%

−0.2

8%

−0.2

25%

12

22

F

2+

60%

IM

+0.1

6%

−0.3

5%

+0.1

8%

−0.5

14%

+0.1

13%

13

30

F

0

20%

PO

+0.8

89%

−0.4

8%

+0.1

8%

−0.9

25%

+0.4

100%

14

38

M

1+

50%

IM

−0.3

17%

+0.2

5%

+0.2

17%

+0.1

5%

−0.1

13%

15

40

F

0

33%

IM

+0.3

21%

−0.3

6%

+0.3

30%

−0.8

26%

+0.2

33%

16

25

F

2+

82%

IM

−0.3

20%

+0.8

19%

−0.1

10%

+1.1

44%

−0.2

29%

17

25

F

2+

60%

PO

−1.4

58%

−1.3

26%

−0.2

17%

−0.5

19%

−0.6

55%

18

30

F

2+

84%

PO

+0.1

6%

+2.1

42%

−0.2

10%

+2.2

100%

+0.1

13%

19

57

M

2+

60%

IM

−1.3

57%

−1.4

22%

−0.5

33%

−0.4

10%

−0.5

50%

20

26

F

0

−24%

PO

−0.7

41%

−0.6

12%

−1.3

59%

+1

50%

−0.3

38%

21

19

F

1+

45%

PO

+1

111%

−0.4

8%

+0.1

8%

−1

28%

+0.5

125%

22

20

M

0

−11%

IM

+0.4

25%

+0.9

24%

−0.4

33%

+1.1

61%

+0.2

29%

23

4

M

1+

−50%

IM

+0.5

56%

+1.3

35%

+0.2

20%

+0.9

39%

+0.2

50%

24

22

F

2+

86%

PO

−0.2

15%

+0.2

5%

0

0%

+0.3

12%

−0.1

17%

25

30

F

1+

57%

IM

+0.3

38%

−0.4

8%

0

0%

−0.5

14%

+0.1

25%

26

27

M

2+

60%

PO

−0.2

13%

−0.8

15%

−0.1

10%

−0.6

16%

−0.1

14%

27

35

F

2+

78%

IM

+0.1

10%

+0.5

14%

−0.1

10%

+0.6

27%

0

0%

28

22

M

2+

80%

IM

+0.2

18%

−0.4

9%

−0.1

9%

−0.4

14%

+0.1

20%

29

22

F

2+

82%

PO

+0.2

15%

−0.5

10%

+0.1

9%

−0.7

23%

+0.1

17%

30

30

M

2+

60%

PO

−1.5

52%

−0.5

10%

−0.6

38%

+0.8

42%

−0.7

54%